ThermoGenesis Corp. Submits 510(k) Application To FDA For AutoXpress(TM) Cord Blood Processing System

Fri, 09 Feb 2007 02:00 PM EST

... ThermoGenesis Corp. (Nasdaq: KOOL) announced today that the Company has submitted a 510(k) pre-market notification application to the U.S. Food and Drug Administration (FDA) requesting regulatory clearance for its AutoXpress System (AXP(TM)). The AXP automates the isolation and capture of stem cells from umbilical cord blood in a functionally closed system. [click link for full article] ...